{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:33:50Z","timestamp":1776317630535,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Asan Institute for Life Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03496-x","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T12:46:30Z","timestamp":1732279590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinically assessed mycosis fungoides tumor burden index as a prognostic marker in tumor-stage mycosis fungoides: a retrospective cohort study"],"prefix":"10.1007","volume":"317","author":[{"given":"Joon Min","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ik Jun","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong Hyun","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Eun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"3496_CR1","doi-asserted-by":"publisher","unstructured":"Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ (2010) Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 28:4730\u20134739. https:\/\/doi.org\/10.1200\/JCO.2009.27.7665","DOI":"10.1200\/JCO.2009.27.7665"},{"key":"3496_CR2","doi-asserted-by":"publisher","unstructured":"Benner MF, Jansen PM, Vermeer MH, Willemze R (2012) Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood 119:1643\u20131649. https:\/\/doi.org\/10.1182\/blood-2011-08-376319","DOI":"10.1182\/blood-2011-08-376319"},{"key":"3496_CR3","doi-asserted-by":"publisher","unstructured":"Benton EC, Crichton S, Talpur R, Agar NS, Fields PA, Wedgeworth E, Mitchell TJ, Cox M, Ferreira S, Liu P, Robson A, Calonje E, Stefanato CM, Wilkins B, Scarisbrick J, Wain EM, Child F, Morris S, Duvic M, Whittaker SJ (2013) A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome. Eur J Cancer 49:2859\u20132868. https:\/\/doi.org\/10.1016\/j.ejca.2013.04.018","DOI":"10.1016\/j.ejca.2013.04.018"},{"key":"3496_CR4","doi-asserted-by":"publisher","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR (2009) Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 113:5064\u20135073. https:\/\/doi.org\/10.1182\/blood-2008-10-184168","DOI":"10.1182\/blood-2008-10-184168"},{"key":"3496_CR5","first-page":"25","volume":"47","author":"FP Cengiz","year":"2017","unstructured":"Cengiz FP, Emiroglu N, Ozkaya DB, Bahali AG, Su O, Onsun N (2017) <ArticleTitle Language=\u201cEn\u201d>Prognostic evaluation of neutrophil\/lymphocyte ratio in patients with mycosis fungoides. Ann Clin Lab Sci 47:25\u201328","journal-title":"Ann Clin Lab Sci"},{"key":"3496_CR6","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1245\/s10434-017-5836-0","volume":"24","author":"JL Davis","year":"2017","unstructured":"Davis JL, Langan RC, Panageas KS, Zheng J, Postow MA, Brady MS, Ariyan C, Coit DG (2017) Elevated blood neutrophil-to-lymphocyte ratio: a readily available biomarker associated with death due to disease in high risk nonmetastatic melanoma. Ann Surg Oncol 24:1989\u20131996. https:\/\/doi.org\/10.1245\/s10434-017-5836-0","journal-title":"Ann Surg Oncol"},{"key":"3496_CR7","doi-asserted-by":"crossref","unstructured":"Epstein EH Jr., Levin DL, Croft JD Jr., Lutzner MA (1972) Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy findings. Med (Baltim) 51:61\u201372","DOI":"10.1097\/00005792-197201000-00004"},{"key":"3496_CR8","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00277-016-2779-7","volume":"95","author":"R Eren","year":"2016","unstructured":"Eren R, Nizam N, Do\u011fu MH, Mercan S, Erdemir AV, Suyan\u0131 E (2016) Evaluation of neutrophil-lymphocyte ratio in patients with early-stage mycosis fungoides. Ann Hematol 95:1853\u20131857. https:\/\/doi.org\/10.1007\/s00277-016-2779-7","journal-title":"Ann Hematol"},{"key":"3496_CR9","doi-asserted-by":"publisher","unstructured":"Ethier JL, Desautels D, Templeton A, Shah PS, Amir E (2017) Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res 19:2. https:\/\/doi.org\/10.1186\/s13058-016-0794-1","DOI":"10.1186\/s13058-016-0794-1"},{"key":"3496_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/jca.21982","volume":"37","author":"T Gambichler","year":"2022","unstructured":"Gambichler T, Sp\u00e4th J, Said S, Scheel CH, Susok L, Stranzenbach R (2022) Outcome of extracorporeal photopheresis in mycosis fungoides patients is not predicted by quotients of systemic immune-inflammatory biomarkers. J Clin Apher 37:360\u2013366. https:\/\/doi.org\/10.1002\/jca.21982","journal-title":"J Clin Apher"},{"key":"3496_CR11","doi-asserted-by":"publisher","unstructured":"Green SB, Byar DP, Lamberg SI (1981) Prognostic variables in mycosis fungoides. Cancer 47:2671\u20132677. https:\/\/doi.org\/10.1002\/1097-0142(19810601)47:11%3C2671::aid-cncr2820471125%3E3.0.co;2-x","DOI":"10.1002\/1097-0142(19810601)47:11%3C2671::aid-cncr2820471125%3E3.0.co;2-x"},{"key":"3496_CR12","doi-asserted-by":"publisher","unstructured":"Horwitz H SM, Scarisbrick JJ, Dummer, Whittaker S, Duvic M, Kim YH, Quaglino P, Zinzani PL, Bechter O, Eradat H, Pinter-Brown L, Akilov OE, Geskin L, Sanches JA, Ortiz-Romero PL, Weichenthal M, Fisher DC, Walewski J, Trotman J, Taylor K, Dalle S, Stadler R, Lisano J, Bunn V, Little M, Prince HM (2021) Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician\u2019s choice in cutaneous T-cell lymphoma: final data. Blood Adv 5(5098\u20135106). https:\/\/doi.org\/10.1182\/bloodadvances.2021004710","DOI":"10.1182\/bloodadvances.2021004710"},{"key":"3496_CR13","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jaad.2021.03.056","volume":"86","author":"JM Jung","year":"2022","unstructured":"Jung JM, Yoo H, Lim DJ, Won CH, Chang SE, Lee MW, Lee WJ (2022) Clinicoprognostic implications of head and neck involvement by mycosis fungoides: a retrospective cohort study. J Am Acad Dermatol 86:1258\u20131265. https:\/\/doi.org\/10.1016\/j.jaad.2021.03.056","journal-title":"J Am Acad Dermatol"},{"key":"3496_CR14","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","volume":"132","author":"YH Kim","year":"1996","unstructured":"Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT (1996) Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 132:1309\u20131313","journal-title":"Arch Dermatol"},{"key":"3496_CR15","doi-asserted-by":"publisher","unstructured":"Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT (2003) Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 139:857\u2013866. https:\/\/doi.org\/10.1001\/archderm.139.7.857","DOI":"10.1001\/archderm.139.7.857"},{"key":"3496_CR16","doi-asserted-by":"publisher","unstructured":"Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, Dummer R, Hoppe RT, Iscl E (2007) TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:479\u2013484. https:\/\/doi.org\/10.1182\/blood-2006-10-054601","DOI":"10.1182\/blood-2006-10-054601"},{"key":"3496_CR17","doi-asserted-by":"publisher","unstructured":"Lamberg SI, Green SB, Byar DP, Block JB, Clendenning WE, Douglas MC, Epstein EH, Jr., Fuks ZY, Golitz LE, Lorincz AL et al (1984) Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med 100:187\u2013192. https:\/\/doi.org\/10.7326\/0003-4819-100-2-187","DOI":"10.7326\/0003-4819-100-2-187"},{"key":"3496_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jid.2019.07.712","volume":"140","author":"A Mourad","year":"2020","unstructured":"Mourad A, Gniadecki R (2020) Overall survival in mycosis fungoides: a systematic review and meta-analysis. J Invest Dermatol 140:495\u2013497 e495. https:\/\/doi.org\/10.1016\/j.jid.2019.07.712","journal-title":"J Invest Dermatol"},{"key":"3496_CR19","doi-asserted-by":"publisher","unstructured":"Nikolaou VA, Papadavid E, Katsambas A, Stratigos AJ, Marinos L, Anagnostou D, Antoniou C (2009) Clinical characteristics and course of CD8\u2009+\u2009cytotoxic variant of mycosis fungoides: a case series of seven patients. Br J Dermatol 161:826\u2013830. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09301.x","DOI":"10.1111\/j.1365-2133.2009.09301.x"},{"key":"3496_CR20","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3109\/10428194.2015.1057894","volume":"57","author":"S Novelli","year":"2016","unstructured":"Novelli S, Garcia-Muret P, Mozos A, Sierra J, Briones J (2016) Total body-surface area as a new prognostic variable in mycosis fungoides and Sezary syndrome. Leuk Lymphoma 57:1060\u20131066. https:\/\/doi.org\/10.3109\/10428194.2015.1057894","journal-title":"Leuk Lymphoma"},{"key":"3496_CR21","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S, Wood G, Dummer R, Ranki A, Burg G, Heald P, Pittelkow M, Bernengo MG, Sterry W, Laroche L, Trautinger F, Whittaker S, ISCL (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:1713\u20131722. https:\/\/doi.org\/10.1182\/blood-2007-03-055749","journal-title":"Blood"},{"key":"3496_CR22","doi-asserted-by":"publisher","unstructured":"Susok L, Said S, Reinert D, Mansour R, Scheel CH, Becker JC, Gambichler T (2022) The pan-immune-inflammation value and systemic immune-inflammation index in advanced melanoma patients under immunotherapy. J Cancer Res Clin Oncol 148:3103\u20133108. https:\/\/doi.org\/10.1007\/s00432-021-03878-y","DOI":"10.1007\/s00432-021-03878-y"},{"key":"3496_CR23","doi-asserted-by":"publisher","unstructured":"Szor DJ, Dias AR, Pereira MA, Ramos M, Zilberstein B, Cecconello I, Ribeiro U Junior (2018) Prognostic role of neutrophil\/lymphocyte ratio in resected gastric cancer: a systematic review and meta-analysis. Clin (Sao Paulo) 73(e360). https:\/\/doi.org\/10.6061\/clinics\/2018\/e360","DOI":"10.6061\/clinics\/2018\/e360"},{"key":"3496_CR24","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","volume":"18","author":"R Talpur","year":"2012","unstructured":"Talpur R, Singh L, Daulat S, Liu P, Seyfer S, Trynosky T, Wei W, Duvic M (2012) Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009. Clin Cancer Res 18:5051\u20135060. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0604","journal-title":"Clin Cancer Res"},{"key":"3496_CR25","doi-asserted-by":"publisher","unstructured":"Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(dju124). https:\/\/doi.org\/10.1093\/jnci\/dju124","DOI":"10.1093\/jnci\/dju124"},{"key":"3496_CR26","first-page":"2212","volume":"95","author":"B Vergier","year":"2000","unstructured":"Vergier B, de Muret A, Beylot-Barry M, Vaillant L, Ekouevi D, Chene G, Carlotti A, Franck N, Dechelotte P, Souteyrand P, Courville P, Joly P, Delaunay M, Bagot M, Grange F, Fraitag S, Bosq J, Petrella T, Durlach A, De Mascarel A, Merlio JP, Wechsler J (2000) Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood 95:2212\u20132218","journal-title":"Blood"},{"key":"3496_CR27","doi-asserted-by":"publisher","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768\u20133785. https:\/\/doi.org\/10.1182\/blood-2004-09-3502","DOI":"10.1182\/blood-2004-09-3502"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03496-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T13:02:55Z","timestamp":1732280575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03496-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3496"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03496-x","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The funding sources had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, and approval of the manuscript; and the decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the Funder\/Sponsor"}},{"value":"None.Neither this manuscript nor one with substantially similar content under our authorship has been presented or published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the relevant institutional review board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"42"}}